Related Experiment Video
Updated: Jun 7, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
Published on: June 4, 2012
Enterococcus faecalis endocarditis severity in rabbits is reduced by IgG Fabs interfering with aggregation substance
Patrick M Schlievert1, Olivia N Chuang-Smith, Marnie L Peterson
1Department of Microbiology, University of Minnesota Medical School, Minneapolis, Minnesota, United States of America. schli001@umn.edu
Enterococcal aggregation substance (AS) contributes to infective endocarditis. While antibodies against AS worsened disease, Fab fragments offered protection by preventing bacterial aggregation and reducing vegetation severity.
Area of Science:
- Microbiology
- Immunology
- Infectious Diseases
Background:
- Enterococcus faecalis is a primary cause of infective endocarditis.
- Enterococcal aggregation substance (AS) is a key virulence factor in endocarditis, promoting bacterial aggregation.
- Endocarditis can occur even without AS production.
Purpose of the Study:
- To evaluate the protective potential of antibodies against AS in a rabbit model of E. faecalis endocarditis.
- To investigate the role of IgG and its Fab fragments in AS-mediated virulence.
Main Methods:
- Active immunization of rabbits against AS+ or AS- E. faecalis.
- Passive administration of anti-AS IgG Fabs before bacterial challenge.
- Assessment of vegetation formation, microbial counts, and size in vivo.
- In vitro assays to measure bacterial aggregation.
Main Results:
- Active immunization against AS+ E. faecalis led to more severe vegetations and higher mortality compared to immunization against AS- E. faecalis.
- IgG antibodies against AS enhanced bacterial aggregation in vitro.
- Passive administration of anti-AS Fab fragments significantly reduced vegetation microbial counts and size.
- Anti-AS Fabs inhibited bacterial aggregation in vitro.
Conclusions:
- The study confirms AS's role in E. faecalis infective endocarditis.
- IgG antibodies against AS can exacerbate the disease by promoting aggregation.
- Anti-AS Fab fragments demonstrate therapeutic potential by preventing aggregation and reducing disease severity.
Related Concept Videos
Endocarditis III: Medical Management
Endocarditis I: Introduction
Endocarditis IV: Nursing Management
Endocarditis II: Clinical Features of Infective Endocarditis
Clinical Significance of Antibiotic Resistance
Rheumatic Heart Disease I: Introduction